352105 <common-name>4-[(e)-3-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)anilino]-3-oxoprop-1-enyl]-n-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)phenyl]benzamide</common-name> <description>4-[(e)-3-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)anilino]-3-oxoprop-1-enyl]-n-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)phenyl]benzamide is a chemical compound with the formula C32H30N10O2. With an average molecular weight of 586.60 g/mol, 4-[(e)-3-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)anilino]-3-oxoprop-1-enyl]-n-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)phenyl]benzamide is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>6446963</pubchem-id> <chemical-formula>C32H30N10O2</chemical-formula> <weight>586.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T18:15:14Z</created-at> <updated-at type="dateTime">2026-08-31T18:15:14Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CN1C=C(C(=NC1=N)N)C2=CC=C(C=C2)NC(=O)C=CC3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)C5=CN(C(=N)N=C5N)C</moldb-smiles> <moldb-formula>C32H30N10O2</moldb-formula> <moldb-inchi>InChI=1S/C32H30N10O2/c1-41-17-25(28(33)39-31(41)35)20-8-12-23(13-9-20)37-27(43)16-5-19-3-6-22(7-4-19)30(44)38-24-14-10-21(11-15-24)26-18-42(2)32(36)40-29(26)34/h3-18H,1-2H3,(H,37,43)(H,38,44)(H3,33,35,39)(H3,34,36,40)/b16-5+</moldb-inchi> <moldb-inchikey>RFGKAJAZMRBGCR-FZSIALSZSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">586.2553202</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM347998</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>4-[(e)-3-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)anilino]-3-oxoprop-1-enyl]-n-[4-(4-amino-2-imino-1-methylpyrimidin-5-yl)phenyl]benzamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Anilides</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0302395</sync-id> <structure-inchikey>RFGKAJAZMRBGCR-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>41800000000040000000000000000000000000000100000002000000000000800000000000010000008000002000000000080000000000800002000000000000000000000000000000000110000020000000000200000000000000000000000000010000001010000000020000800000000100000000000000000001000000000040000400000000000000004080801004000000000000000000000000000000080000000000000000084000004000000400005000000000000000000000000000000000000000000000000000400000104000000000000200000800001000008000000001000040000000000400000000000000200000000000004010</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAAMAAAAIABBgBgAAAAAQMHQCgAAAAD AwZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQHQCgAAAADAwZAKAAAAAMEBwBo AAAAAwIBBwBoAAAAAwECBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgA AAADBAZAaAAAAAMDAQZAaAAAAAMDAQcAaAAAAAMCAQYAKAAAAAMECAAoAAAA AwIGAGgAAAADAwEGAGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMD AQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBgAoAAAAAwQIACgAAAADAgcA aAAAAAMCAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQdAKAAAAAMDBkAoAAAA AwQHAGgAAAADAgEHQCgAAAADAwZAKAAAAAMEBwBoAAAAAwECBgBgAAAAAQML AAEAAQJoDAIDaAwDBGgMBAVoDAUGaAwGBygCBAggAwkgCQpoDAoLaAwLDGgM DA1oDA0OaAwMDyAPECAQESgCEBIgEhMoAhMUIBQVaAwVFmgMFhdoDBcYaAwY GWgMFxogGhsoAhocIBwdIB0eaAweH2gMHyBoDCAhaAwhImgMICMgIyRoDCQl aAwlJmgMJicoAiYoaAwoKWgMKSogJSsABgFoDA4JaAwZFGgMIh1oDCkjaAxC BQAAAAYBBgUEAwIGCgsMDQ4JBhUWFxgZFAYeHyAhIh0GJCUmKCkjFwQAAAAA AAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:49:54Z</structure-indexed-at> </compound>